Evaluating the MSKCC Gastric Cancer Survival Calculator in Turkey
Author Information
Author(s): İlknur Deliktaş Onur, Tuğba Başoğlu, Nazım Can Demircan, Tuğba Akın Telli, Rukiye Arıkan, Özlem Ercelep, Mehmet Akif Öztürk, Perran Fulden Yumuk, Faysal Dane
Primary Institution: University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkiye
Hypothesis
This study aimed to evaluate the predictive power of the MSKCC nomogram in the Turkish patient population.
Conclusion
The MSKCC prognostic tool can be used to predict survival in clinical practice for gastric cancer patients who underwent surgery and R0 resection.
Supporting Evidence
- The 5-year median observed OS rate was 51.7%, while the MSKCC tool estimated it at 48.5%.
- The 9-year median observed OS rate was 41.4%, compared to 41% estimated by the MSKCC tool.
- The study included gastric cancer patients aged 18 years or older who underwent primary curative surgery.
- Statistically significant differences were found in survival rates based on age and tumor stage.
Takeaway
Doctors used a special calculator to predict how long patients with stomach cancer would live after surgery, and it worked pretty well for Turkish patients.
Methodology
The study analyzed the 5- and 9-year overall survival rates of gastric cancer patients who underwent primary curative surgery and R0 resection.
Potential Biases
The calculator does not include comorbidities, which may affect survival outcomes.
Limitations
The study was retrospective, and the adjuvant treatment protocols received by the patients were varied.
Participant Demographics
70.5% male and 29.5% female, mean age at diagnosis was 59.2 years.
Statistical Information
P-Value
0.0001
Confidence Interval
95% CI: 1.16–4.66
Statistical Significance
p = 0.31
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website